City

Rochester (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (1)

National Comprehensive Cancer Network (1)

Intervention

irinotecan (1)

irinotecan hydrochloride (1)

trifluridine and tipiracil hydrochloride (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

refractory gallbladder carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting

Advanced Bile Duct Carcinoma
+17 more

Irinotecan
+2 more

Rochester, Minnesota

Mayo Clinic

Jan 5, 2023